文献速递神经肿瘤

内镜下经鼻手术治疗侵袭性垂体腺瘤:四种入路分析

Endoscopic Endonasal Surgery Treatment Strategies for Invasive Pituitary Adenoma: Analysis of Four Approaches.
PubMed 文献 · World Neurosurg · 2018-03-07

回顾性分析深圳大学第一附属医院神经外科2014年5月至2017年8月收治的74例(75次手术)侵袭性垂体腺瘤患者,采用四种内镜经鼻入路。总体全切除率70.7%,Knosp 3级与4级全切除率分别为89.3%和28.6%(P<0.05),Hardy C、D、E期全切除率分别为90.5%、90.0%、26.1%(P<0.05)。作者认为根据侵袭性选择合适入路有助于切除肿瘤和减少并发症。

要点

  • 总体全切除率70.7%(53例),肿瘤残留率29.3%(22例)。
  • Knosp 3级全切除率89.3%、4级28.6%,生物学治愈率分别为75.0%和23.8%,差异有统计学意义(P<0.05)。
  • Hardy C、D、E期全切除率分别为90.5%、90.0%、26.1%,生物学治愈率分别为80.1%、75.0%、13.0%,差异有统计学意义(P<0.05)。

核心结论

  • 作者认为,根据侵袭性垂体腺瘤的侵袭程度选择合适的内镜手术入路有助于切除肿瘤并减少并发症。

研究设计与样本

  • 回顾性分析2014年5月至2017年8月深圳大学第一附属医院神经外科74例(75次手术)侵袭性垂体腺瘤患者的临床资料。
  • 经海绵窦入路47例,海绵窦侧方入路14例,鞍结节-蝶骨平台入路8例,鞍膈开放或鞍背切除入路6例。

主要发现

  • 总体全切除率70.7%(53例),肿瘤残留率29.3%(22例)。
  • Knosp 3级全切除率89.3%、4级28.6%,生物学治愈率分别为75.0%和23.8%,差异有统计学意义(P<0.05)。
  • Hardy C期全切除率90.5%、D期90.0%、E期26.1%,生物学治愈率分别为80.1%、75.0%、13.0%,差异有统计学意义(P<0.05)。
  • 术后严重并发症包括脑脊液漏9例(12.0%)、电解质紊乱26例(34.7%)、一过性尿崩症36例(48.0%)、垂体功能减退22例(29.3%)、永久性垂体功能减退2例(2.7%)、鼻出血2例(2.7%)。
  • 随访2至41个月(平均19.3个月),全切除后无复发,1例次全切除后复发并再手术,3例术后接受伽玛刀治疗,2例难治性侵袭性垂体腺瘤接受替莫唑胺和二甲双胍化疗。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To explore the surgical methods and clinical effect of endoscopic endonasal approaches for the treatment of invasive pituitary adenomas (IPAs). METHODS: A retrospective analysis was made of the clinical data of 74 patients (75 procedures) with IPAs treated by different endoscopic endonasal approaches at the Department of Neurosurgery, The First Affiliated Hospital of Shenzhen University from May 2014 to August 2017. The data include clinical manifestation, imaging features, surgical methods and complications, resection rate, cure rate, prognosis, and complications in different Knosp classifications and Hardy stages. The transcavernous approach was used in 47 patients, the lateral-cavernous approach was used in 14 patients, the tuberculum sella planum approach was used in 8 patients, and the diaphragma sellae open or dorsum sellae cut approach was used in 6 patients. RESULTS: The gross total resection (GTR) rate was 70.7% (53 patients) and tumor residue rate was 29.3% (22 patients). GTR rate for pituitary adenoma according to Knosp classification was 89.3% in grade 3 and 28.6% in grade 4. The biology cure rate was 75.0% and 23.8%, respectively. There was significance between them (P < 0.05). In addition, the GTR rate of Hardy stage was 90.5% in stage C, 90.0% in stage D, 26.1% in stage E, and the biology cure rate was 80.1%, 75.0%, and 13.0%, respectively. There was significance among them (P < 0.05) Postoperative severe complications included 9 patients (12.0%) with cerebrospinal fluid leaks, 26 patients (34.7%)with electrolyte imbalance, 36 patients (48.0%) with transient diabetes insipidus, 22 patients (29.3%) with hypopituitarism, 2 patients (2.7%) with permanent hypopituitarism, and 2 patients (2.7%)with epistaxis. The follow-up lasted 2-41 months (average, 19.3 months). No patient experienced recurrence after GTR, 1 patient undergoing subtotal experienced recurrence and underwent reoperation, 3 patients underwent postoperative Gamma Knife treatment, and 2 patients with refractory IPA were given temozolomide and metformin chemotherapy. CONCLUSIONS: According to the invasiveness of IPA, choosing the appropriate endoscopic surgical approach is helpful in removing tumors and reducing complications.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ji-Hu Y, Guo-Dong H, Tao J, et al. Endoscopic Endonasal Surgery Treatment Strategies for Invasive Pituitary Adenoma: Analysis of Four Approaches. World Neurosurg. 2018. PMID: 29524704. doi:10.1016/j.wneu.2018.02.162

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。